パーキンソン病の病原性
Huw R Morris1, Maria Grazia Spillantini2, Carolyn M Sue3
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK; University College London Movement Disorders Centre, University College London, London, UK; Aligning Science Across Parkinson's Collaborative Research Network, Chevy Chase, MD, USA.
Lancet (London, England)
|January 20, 2024
まとめ
パーキンソン病は,アルファシヌクレインの蓄積と拡散を伴い,細胞機能と免疫反応に影響します. 研究は,病気の進行を止めるための神経保護療法を開発するための基礎を提供します.
科学分野:
- 神経科学
- 病理学について
- 遺伝学
背景:
- パーキンソン病は,アルファ-シヌクレインの蓄積によって特徴づけられる進行性神経変性疾患である.
- その病原性を理解するには,遺伝学,分子病理学,細胞機構が含まれます.
研究 の 目的:
- パーキンソン病の病原性に関する現在の洞察をレビューする.
- 細胞および分子発見に基づいた潜在的な治療戦略を探求する.
主な方法:
- 遺伝学と分子病理学の研究のレビュー
- 生化学研究,移植ニューロン研究,細胞/動物モデル分析.
- 細胞機能 (ミトコンドリア,リンソーム,エンドソーム) と免疫反応の検査
主要な成果:
- アルファシヌクレインの異常な集積とその拡散 (腸-脳軸) は,疾患発症に関与している.
- 細胞機能障害 (ミトコンドリア,リソソーム,エンドソーム) は遺伝的および散発的な形態の両方で観察されます.
- 免疫反応や炎症反応は 潜在的に腸に起因し パーキンソン病の発生を加速します
結論:
- 現在の研究は 神経保護療法の開発のための基盤を提供します.
- パーキンソン病の進行を止めることです
- 現在,病気を修正する治療法はありませんが,合理的な治療法の開発は有望です.
関連する概念動画
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
657
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
657
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


